Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Mirador Therapeutics

Request full access

A next-generation precision medicine company focused on immunology and inflammation

San Diego, United StatesFounded 2024Biotech & Life Sciences

About Mirador Therapeutics

Mirador Therapeutics is a pioneering company in the field of precision medicine, focusing on immune-mediated inflammatory and fibrotic diseases. The company leverages advanced biology, multi-modal data, and sophisticated analytics to develop transformational therapies aimed at improving patient outcomes. Founded by former executives of Prometheus Biosciences, which was acquired by Merck for $10.8 billion, Mirador Therapeutics operates in the biotechnology sector. Its business model revolves around the development and commercialization of precision therapies, targeting healthcare providers and patients suffering from immune-mediated conditions. Revenue is generated through the sale of these specialized treatments and potential partnerships with larger pharmaceutical companies.

Source: Dealroom company data

At a glance

Status
Operational
Employees
95
Open positions
2
Dealroom signal
92.8/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Precision Medicine, Rumoured $1B, Biotech and Pharma, DT and LS, science-based
Technology
Big Data
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Jan 2026 $250M $2B Farallon Capital Management · Fidelity Investments · ARCH Venture Partners · OrbiMed ↗
SERIES AOther financing Mar 2024 $400M $1.6B Farallon Capital Management · ARCH Venture Partners · OrbiMed · Point72 Ventures ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Mirador Therapeutics website traffic

Latest recorded traffic for Mirador Therapeutics is 7.2K monthly website visits, up 20% over the last three months. Mirador Therapeutics's team grew 4.4% over the past year.

Latest monthly visits7.2K 3-month web change+20% 1-year team growth+4.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Mirador Therapeutics in the San Diego ecosystem

Live from Dealroom

The Mirador Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

20 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A20 investors entered at this stage

  • Farallon Capital Management
  • ARCH Venture Partners
  • OrbiMed
  • Point72 Ventures
  • Alexandria Venture Investments
  • RTW Investments
  • Woodline Partners
  • Fairmount Funds Management
  • Blue Owl Capital
  • Fidelity Investments
  • Invus
  • Sanofi Ventures
  • Boxer Capital
  • Logos Capital
  • Moore Strategic Ventures
  • TCGX
  • Venrock Healthcare Capital Partners
  • Fairmount Partners
  • Adage Capital
  • T. Rowe Price
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Mirador Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.